vTv Therapeutics (VTVT)

vTv Therapeutics (VTVT) Financial Statements


vTv Therapeutics Financial Overview

vTv Therapeutics's market cap is currently ―. The company's EPS TTM is $-8.867; its P/E ratio is -3.13; vTv Therapeutics is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue---$ 9.00K$ 0.00
Gross Profit---$ -159.00K-
EBIT$ -8.54M$ -7.21M$ -5.87M$ -6.24M$ -5.46M
EBITDA-$ -7.19M$ -5.85M$ -6.21M$ -5.44M
Net Income Common Stockholders$ -6.65M$ -5.62M$ -4.50M$ -4.75M$ -4.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.24M$ 12.60M$ 18.78M$ 12.14M$ 15.34M
Total Assets$ 14.92M$ 22.43M$ 28.64M$ 33.24M$ 35.52M
Total Debt$ 851.00K$ 417.00K$ 454.00K$ 716.00K$ 1.10M
Net Debt$ -7.39M$ -12.18M$ -18.33M$ -11.43M$ -14.24M
Total Liabilities$ 29.43M$ 28.83M$ 28.42M$ 27.40M$ 52.09M
Stockholders Equity$ -25.23M$ -25.28M$ -19.42M$ -10.74M$ -16.57M
Cash Flow-
Free Cash Flow-$ -6.17M$ -5.17M$ -6.88M$ -8.83M
Operating Cash Flow$ -4.83M$ -6.17M$ -5.17M$ -6.88M$ -8.83M
Investing Cash Flow----$ 0.00
Financing Cash Flow$ 473.00K-$ 11.81M$ 3.67M$ 6.30M
Currency in USD

vTv Therapeutics Earnings and Revenue History

vTv Therapeutics Debt to Assets

vTv Therapeutics Cash Flow

vTv Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis